Since the publication of the Duchenne muscular dystrophy (DMD) care considerations in
2010, multidisciplinary care of this severe, progressive neuromuscular disease has evolved …

Improvements in the function, quality of life, and longevity of patients with Duchenne
muscular dystrophy (DMD) have been achieved through a multidisciplinary approach to …

Duchenne muscular dystrophy (DMD) is a progressive muscle-wasting disorder. It is caused
by loss-of-function mutations in the dystrophin gene. Currently, there is no cure. A highly …

Muscular dystrophies are a heterogeneous group of inherited disorders that share similar
clinical features and dystrophic changes on muscle biopsy. An improved understanding of …

Aim Duchenne muscular dystrophy (DMD) is associated with neuropsychiatric disorders.
The aim of the study was to characterize the DMD neuropsychiatric profile fully and to …

Duchenne muscular dystrophy (DMD) is caused by frameshift mutations in the DMD gene
that prevent the body-wide translation of its protein product, dystrophin. Besides a severe …

Duchenne muscular dystrophy is a progressive neuromuscular condition that has a high rate
of cognitive and learning disabilities as well as neurobehavioral disorders, some of which …

Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy in
childhood. It is caused by mutations of the DMD gene, leading to progressive muscle …

Many neuromuscular diseases are genetically inherited or caused by mutations in motor
function proteins. Two of the most prevalent neuromuscular diseases are Duchenne …

Abstract The coronavirus disease 2019 (COVID‐19) pandemic has resulted in the
reorganization of health‐care settings affecting clinical care delivery to patients with …